Leptolide improves insulin resistance in diet-induced obese mice

This article belongs to the Special Issue Marine Compounds and Inflammation II, 2017.

Saved in:
Bibliographic Details
Main Authors: Villa-Pérez, Pablo, Cueto, Mercedes, Díaz-Marrero, Ana R., Lobatón, Carmen D., Moreno, Alfredo, Perdomo, Germán, Cózar-Castellano, Irene
Other Authors: Ministerio de Economía y Competitividad (España)
Format: artículo biblioteca
Published: Molecular Diversity Preservation International 2017
Subjects:HepG2 cells, Insulin resistance, Obesity, Type 2 diabetes, Leptolide,
Online Access:http://hdl.handle.net/10261/158149
http://dx.doi.org/10.13039/501100003329
http://dx.doi.org/10.13039/501100003339
http://dx.doi.org/10.13039/501100014180
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-ipna-es-10261-158149
record_format koha
spelling dig-ipna-es-10261-1581492021-12-28T16:03:58Z Leptolide improves insulin resistance in diet-induced obese mice Villa-Pérez, Pablo Cueto, Mercedes Díaz-Marrero, Ana R. Lobatón, Carmen D. Moreno, Alfredo Perdomo, Germán Cózar-Castellano, Irene Ministerio de Economía y Competitividad (España) Junta de Castilla y León Fundación de la Sociedad Española de Diabetes Consejo Superior de Investigaciones Científicas (España) HepG2 cells Insulin resistance Obesity Type 2 diabetes Leptolide This article belongs to the Special Issue Marine Compounds and Inflammation II, 2017. Type 2 diabetes (T2DM) is a complex disease linked to pancreatic beta-cell failure and insulin resistance. Current antidiabetic treatment regimens for T2DM include insulin sensitizers and insulin secretagogues. We have previously demonstrated that leptolide, a member of the furanocembranolides family, promotes pancreatic beta-cell proliferation in mice. Considering the beneficial effects of leptolide in diabetic mice, in this study, we aimed to address the capability of leptolide to improve insulin resistance associated with the pathology of obesity. To this end, we tested the hypothesis that leptolide should protect against fatty acid-induced insulin resistance in hepatocytes. In a time-dependent manner, leptolide (0.1 µM) augmented insulin-stimulated phosphorylation of protein kinase B (PKB) by two-fold above vehicle-treated HepG2 cells. In addition, leptolide (0.1 µM) counteracted palmitate-induced insulin resistance by augmenting by four-fold insulin-stimulated phosphorylation of PKB in HepG2 cells. In vivo, acute intraperitoneal administration of leptolide (0.1 mg/kg and 1 mg/kg) improved glucose tolerance and insulin sensitivity in lean mice. Likewise, prolonged leptolide treatment (0.1 mg/kg) in diet-induced obese mice improved insulin sensitivity. These effects were paralleled with an ~50% increased of insulin-stimulated phosphorylation of PKB in liver and skeletal muscle and reduced circulating pro-inflammatory cytokines in obese mice. We concluded that leptolide significantly improves insulin sensitivity in vitro and in obese mice, suggesting that leptolide may be another potential treatment for T2DM This research has been funded by Sociedad Española de Diabetes (Ayudas Investigación Básica 2014), Salud Castilla y León (BIO/VA40/15) and Ministerio de Economía y Competitividad-Spain (SAF2014-58702-C2-1-R) to I.C. and Ministerio de Economía y Competitividad-Spain (SAF2014-58702-C2-2-R) to G.P. We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI). Peer Reviewed 2017-12-13T10:51:01Z 2017-12-13T10:51:01Z 2017 2017-12-13T10:51:01Z artículo http://purl.org/coar/resource_type/c_6501 doi: 10.3390/md15090289 issn: 1660-3397 Marine Drugs 15(9): 2889 (2017) http://hdl.handle.net/10261/158149 10.3390/md15090289 http://dx.doi.org/10.13039/501100003329 http://dx.doi.org/10.13039/501100003339 http://dx.doi.org/10.13039/501100014180 28914811 #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2014-58702-C2-2-R info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2014-58702-C2-1-R Publisher's version Sí open Molecular Diversity Preservation International
institution IPNA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-ipna-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IPNA España
topic HepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
HepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
spellingShingle HepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
HepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
Villa-Pérez, Pablo
Cueto, Mercedes
Díaz-Marrero, Ana R.
Lobatón, Carmen D.
Moreno, Alfredo
Perdomo, Germán
Cózar-Castellano, Irene
Leptolide improves insulin resistance in diet-induced obese mice
description This article belongs to the Special Issue Marine Compounds and Inflammation II, 2017.
author2 Ministerio de Economía y Competitividad (España)
author_facet Ministerio de Economía y Competitividad (España)
Villa-Pérez, Pablo
Cueto, Mercedes
Díaz-Marrero, Ana R.
Lobatón, Carmen D.
Moreno, Alfredo
Perdomo, Germán
Cózar-Castellano, Irene
format artículo
topic_facet HepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
author Villa-Pérez, Pablo
Cueto, Mercedes
Díaz-Marrero, Ana R.
Lobatón, Carmen D.
Moreno, Alfredo
Perdomo, Germán
Cózar-Castellano, Irene
author_sort Villa-Pérez, Pablo
title Leptolide improves insulin resistance in diet-induced obese mice
title_short Leptolide improves insulin resistance in diet-induced obese mice
title_full Leptolide improves insulin resistance in diet-induced obese mice
title_fullStr Leptolide improves insulin resistance in diet-induced obese mice
title_full_unstemmed Leptolide improves insulin resistance in diet-induced obese mice
title_sort leptolide improves insulin resistance in diet-induced obese mice
publisher Molecular Diversity Preservation International
publishDate 2017
url http://hdl.handle.net/10261/158149
http://dx.doi.org/10.13039/501100003329
http://dx.doi.org/10.13039/501100003339
http://dx.doi.org/10.13039/501100014180
work_keys_str_mv AT villaperezpablo leptolideimprovesinsulinresistanceindietinducedobesemice
AT cuetomercedes leptolideimprovesinsulinresistanceindietinducedobesemice
AT diazmarreroanar leptolideimprovesinsulinresistanceindietinducedobesemice
AT lobatoncarmend leptolideimprovesinsulinresistanceindietinducedobesemice
AT morenoalfredo leptolideimprovesinsulinresistanceindietinducedobesemice
AT perdomogerman leptolideimprovesinsulinresistanceindietinducedobesemice
AT cozarcastellanoirene leptolideimprovesinsulinresistanceindietinducedobesemice
_version_ 1777669730482520064